| Literature DB >> 35095097 |
Jineng Lv1, Haitao Xi2, Xiujuan Lv1, Yue Zhou1, Jiahua Wang1, Haoran Chen1, Tong Yan1, Jiang Jin3, Junzhao Zhao2, Feng Gu4, Zongming Song5.
Abstract
CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated endonuclease Cas9) nucleases have been widely applied for genome engineering. Staphylococcus aureus Cas9 (SaCas9) is compact, which can be packaged in AAV (adeno-associated virus) vector for in vivo gene editing. While, wild-type SaCas9 can induce unwanted off-target mutations and substantially limits the applications. So far, there are two reported SaCas9 variants with high-fidelity, including efSaCas9 from our previous study and SaCas9-HF. However, it remains unknown which one possessing the better fidelity and higher activity. Here, we performed a parallel comparison of efSaCas9 and SaCas9-HF in human cells through fluorescent reporter system and target deep sequencing, respectively. The results demonstrated that efSaCas9 possesses higher cleavage activity and fidelity than SaCas9-HF at the most endogenous sites in human cells. Collectively, our study provides insights for the rational selection of suitable SaCas9 for human genome editing.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35095097 DOI: 10.1038/s41434-022-00319-4
Source DB: PubMed Journal: Gene Ther ISSN: 0969-7128 Impact factor: 4.184